Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
33700 Results Found
340B Advocacy Alliance Bulletin: Last Chance to Register for Today’s 340B Alliance Call at 3 p.m. ET
The AHA 340B Advocacy Alliance today, Feb.
Special Bulletin: CMS Releases CY 2021 Proposed Rule for Physician Fee Schedule Payments
The Centers for Medicare & Medicaid Services (CMS) Aug. 3 issued a proposed rule that would update physician fee schedule (PFS) payments for calendar year (CY) 2021. The rule also included several proposals to implement year five of the quality payment program (QPP) created by the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015.
Restoring Consumer Confidence
Today, more than ever, patient experience and convenience are having a stronger influence on how consumers choose providers
Inpatient Psychiatric Facility PPS: Final Rule for FY 2021
The Centers for Medicare & Medicaid Services (CMS) July 31 published a final rule for the inpatient psychiatric facility (IPF) prospective payment system (PPS) for fiscal year (FY) 2021. The rule will be published in the Federal Register Aug. 4.
Special Bulletin: White House Releases Executive Order on Improving Rural Health and Telehealth Access
The White House Aug.
AHA Comments on CMS’ Proposed Rule on Prior Authorization
AHA comments on CMS’ proposed rule on prior authorization.
AHA Urges ONC to Further Delay Information Blocking Provisions
AHA urges the Department of Health and Human Services’ Office of the National Coordinator for Health Information Technology to extend the deadline to comply with its final rule implementing information blocking provisions of the 21st Century Cures Act to 2022 or six months after the end of the COVID-19 public health emergency, whichever is later. The current deadline is April 5, 2021.
Detailed Summary of Health Provisions in Consolidated Appropriations Act, 2021
The House and Senate last night approved the
Pfizer data indicates COVID-19 vaccine stability in non-ultra-cold temperatures
New data from Pfizer Inc. indicates that its COVID-19 vaccine is more stable than previously believed when stored -25°C to -15°C (-13°F to 5°F), temperatures more commonly found in pharmaceutical freezers and refrigerators.